Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multiepitopic HLA-A*0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization.

Journal of immunology (Baltimore, Md. : 1950) - 15 Oct 2000

Loirat D, Lemonnier F A, Michel M L

Abstract excerpt

CTL together with anti-envelope Abs represent major effectors for viral clearance during hepatitis B virus (HBV) infection. The induction of strong cytotoxic and Ab responses against the envelope proteins after DNA-based immunization has been proposed as a promising therapeutic approach to mediat...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigen Presentation
Share to Cytotoxicity, Immunologic
Share to Epitopes, T-Lymphocyte

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B Surface Antigens

Share to Hepatitis B Vaccines

Share to HLA-A2 Antigen

Share to T-Lymphocytes, Cytotoxic

Share to Vaccines, DNA

Source

Identifiers

PMID: 11035120
DOI: 10.4049/jimmunol.165.8.4748

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-11035120-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multiepitopic HLA-A*0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization.PMID 11035120Read ↗

Rational Design of a Multiepitope Vaccine Encoding T-Lymphocyte Epitopes for Treatment of Chronic Hepatitis B Virus InfectionsSemantic proximity Read ↗

Development of a humanized HLA-A2.1/DP4 transgenic mouse model and the use of this model to map HLA-DP4-restricted epitopes of HBV envelope protein.Semantic proximity Read ↗

CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1.Semantic proximity Read ↗

DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state.Semantic proximity Read ↗

Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice.Semantic proximity Read ↗

DNA-based immunization breaks tolerance in a hepatitis C virus transgenic mouse model.Semantic proximity Read ↗

Humanized mouse model reveals the immunogenicity of Hepatitis B Virus vaccine candidates produced in CRISPR/Cas9-edited Nicotiana benthamianaSemantic proximity Read ↗

Optimized vaccination regimen linked to exhaustive screening approaches identifies 2 novel HLA-B7 restricted epitopes within hepatitis C virus NS3 protein.Semantic proximity Read ↗

A mechanism to explain the selection of the hepatitis e antigen-negative mutant during chronic hepatitis B virus infection.Semantic proximity Read ↗

Immunobiology and Pathogenesis of Hepatocellular Injury in Hepatitis B Virus Transgenic MiceSemantic proximity Read ↗

Application of Humanized MHC Transgenic Mice in the Screening of HLA–Restricted T Cell Epitopes for Influenza VaccinesSemantic proximity Read ↗

Type 2 autoimmune hepatitis murine model: the influence of genetic background in disease development.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.